
Habibeh Khoshbouei
Articles
-
Nov 13, 2023 |
psypost.org | Habibeh Khoshbouei
The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy. Adderall became a go-to drug for ADHD over the past two decades but quickly came under fire because of overprescription and misuse.
-
Apr 12, 2023 |
triblive.com | Habibeh Khoshbouei
The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy. Adderall became a go-to drug for ADHD over the past two decades but quickly came under fire because of overprescription and misuse.
-
Apr 10, 2023 |
medicalxpress.com | Habibeh Khoshbouei
The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy. Adderall became a go-to drug for ADHD over the past two decades but quickly came under fire because of overprescription and misuse.
-
Apr 7, 2023 |
fortune.com | Habibeh Khoshbouei
Through this work, I aim to better understand the complex interplay between drug use and the dopamine system, which may ultimately lead to new treatments for drug addiction and related disorders. Unfortunately, I’ve seen that the stigma and false narratives surrounding Adderall have made it more difficult for patients who need this medication to access it. How Adderall treats ADHDThe underlying processes that lead to ADHD are poorly understood.
-
Apr 7, 2023 |
tolerance.ca | Habibeh Khoshbouei
© 2023 Tolerance.ca® Inc. All reproduction rights reserved. All information reproduced on the Web pages of www.tolerance.ca (including articles, images, photographs, and logos) is protected by intellectual property rights owned by Tolerance.ca® Inc. or, in certain cases, by its author. Any reproduction of the information for use other than personal use is prohibited.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →